These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2233996)

  • 1. Immune function in heroin addicts and former heroin addicts in treatment: pre- and post-AIDS epidemic.
    Kreek MJ
    NIDA Res Monogr; 1990; 96():192-219. PubMed ID: 2233996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
    Novick DM; Ochshorn M; Ghali V; Croxson TS; Mercer WD; Chiorazzi N; Kreek MJ
    J Pharmacol Exp Ther; 1989 Aug; 250(2):606-10. PubMed ID: 2788218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the opioid antagonist naloxone on human natural killer cell activity in vitro.
    Adelson MO; Novick DM; Khuri E; Albeck H; Hahn EF; Kreek MJ
    Isr J Med Sci; 1994 Sep; 30(9):679-84. PubMed ID: 8088979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function.
    Sacerdote P; Franchi S; Gerra G; Leccese V; Panerai AE; Somaini L
    Brain Behav Immun; 2008 May; 22(4):606-13. PubMed ID: 18294814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiology of addictive behaviors and its relationship to methadone maintenance.
    Stimmel B; Kreek MJ
    Mt Sinai J Med; 2000; 67(5-6):375-80. PubMed ID: 11064487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
    Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
    Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of the effect of methadone on natural killer cell activity.
    Ochshorn M; Novick DM; Kreek MJ
    Isr J Med Sci; 1990 Aug; 26(8):421-5. PubMed ID: 2401603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological function in active heroin addicts and methadone-maintained former addicts: observations and possible mechanisms.
    Kreek MJ
    NIDA Res Monogr; 1990; 105():75-81. PubMed ID: 1876153
    [No Abstract]   [Full Text] [Related]  

  • 9. Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.
    Kling MA; Carson RE; Borg L; Zametkin A; Matochik JA; Schluger J; Herscovitch P; Rice KC; Ho A; Eckelman WC; Kreek MJ
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1070-6. PubMed ID: 11082442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between heroin and heroin-cocaine polyabusers: a psychopathological study.
    Bandettini Di Poggio A; Fornai F; Paparelli A; Pacini M; Perugi G; Maremmani I
    Ann N Y Acad Sci; 2006 Aug; 1074():438-45. PubMed ID: 17105942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers.
    De Castro S; Sabaté E
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S464-7. PubMed ID: 14648465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of heroin trends in New York City: past, present and future.
    Frank B
    Mt Sinai J Med; 2000; 67(5-6):340-6. PubMed ID: 11064484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of personality traits and drug of choice by cocaine addicts and heroin addicts.
    Gerra G; Bertacca S; Zaimovic A; Pirani M; Branchi B; Ferri M
    Subst Use Misuse; 2008; 43(3-4):317-30. PubMed ID: 18365934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone maintenance treatment (MMT): a review of historical and clinical issues.
    Joseph H; Stancliff S; Langrod J
    Mt Sinai J Med; 2000; 67(5-6):347-64. PubMed ID: 11064485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Difference in the behavior of T-lymphocyte populations in heroin and methadone addicts].
    Brugo MA; Guffanti A; Guzzetti S; Pedretti D; Stringhetti M; Confalonieri F
    Boll Ist Sieroter Milan; 1983; 62(6):517-23. PubMed ID: 6234006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of lymphocyte opioid receptors in methadone maintenance subjects.
    Toskulkao T; Pornchai R; Akkarapatumwong V; Vatanatunyakum S; Govitrapong P
    Neurochem Int; 2010 Jan; 56(2):285-90. PubMed ID: 19913582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune status of unselected methadone maintained former heroin addicts.
    Kreek MJ; Khuri E; Flomenberg N; Albeck H; Ochshorn M
    Prog Clin Biol Res; 1990; 328():445-8. PubMed ID: 2304962
    [No Abstract]   [Full Text] [Related]  

  • 18. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients.
    Novick DM; Joseph H; Croxson TS; Salsitz EA; Wang G; Richman BL; Poretsky L; Keefe JB; Whimbey E
    Arch Intern Med; 1990 Jan; 150(1):97-9. PubMed ID: 2297301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts.
    Fernandez-Cruz E; Fernandez AM; Gutierrez C; Garcia-Montes M; de la Morena MT; Rodriguez-Villanueva J; Longo N; Zabay JM
    Clin Exp Immunol; 1988 May; 72(2):190-5. PubMed ID: 3261660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.